Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan and Ramipril in Type 1 Diabetic Nephropathy
NCT00738660Phase 3Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Feb 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of telmisartan and ramipril in diabetic nephropathy (DN), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Reduction in Albumin Excretion Rate at 8 weeks. Started Feb 2007; status: completed.
02
Drugs
telmisartanramipril
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00738660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00738660.